g 25671 has been researched along with Coronary Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eller, BT; Lucchesi, BR; Lynch, JJ; Patterson, E | 1 |
1 other study(ies) available for g 25671 and Coronary Disease
| Article | Year |
|---|---|
Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Cyclooxygenase Inhibitors; Dogs; Electrophysiology; Male; Myocardial Infarction; Sulfinpyrazone; Ventricular Fibrillation | 1987 |